Alessia Ciarrocchi

41PUBLICATIONS
140CO-AUTHORS
Medical infection agents (incl. prions)Molecular targetsGenomicsGene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|Aug 04, 2026
DRP1-mediated mitochondrial fragmentation is a druggable vulnerability in multiple myeloma.

|Jul 08, 2026
BET inhibition unmasks a targetable glycolytic dependency through a HIF1α stabilization and driven transcriptional program in a defined subset of triple-negative breast Cancer.

|May 13, 2026
MDM2 Drives Proteasome Inhibitor Resistance and Represents a TP53-Independent Therapeutic Vulnerability in Multiple Myeloma.

|Mar 20, 2026
The dual impact of GBA1 in disease: from germline mutations in neurological disorders to alterations in cancer.

Valentina Fantini, Giulia Di Rauso, Valentina Fioravanti

|Feb 26, 2026
Immune Checkpoint Inhibitors in Malignant Pleural Mesothelioma: Efficacy, Real-World Outcomes, and the Search for Predictive Biomarkers.

Giusi Bondì, Serafina Martella, Dimitrios Stylianakis

|Aug 12, 2025
Endometrial carcinoma and immune escape: prognostic relevance of HLA class I loss in NSMP subtype.

Marco Grillini, Jacopo Lenzi, Claudio Ceccarelli

Pageof 7

Frequent Collaborators

7 joint publications

Benedetta Donati

6 joint publications

Elisabetta Sauta

6 joint publications

Valentina Sancisi

6 joint publications

Gloria Manzotti